India Patient Support Programs (PSP) Market Analysis
insights10marketing
160 views
68 slides
Aug 08, 2024
Slide 1 of 68
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
About This Presentation
This report presents a strategic analysis of the India Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & fut...
Slide Content
India Patient Support Programs (PSP)
Market Analysis
A sample report on
Market Analysis
A sample report on
This report presents a strategic analysis of the India Patient Support
Programs (PSP) Market and a forecast for its development in the
medium and long term. It provides a comprehensive overview of the
market value, dynamics, segmentation, main players, growth and
demand drivers, challenges & future outlook, etc. This is one of the
most comprehensive reports about the India Patient Support
Programs (PSP) Market, and offers unmatched value, accuracy, and
expert insights.
Programs (PSP) Market and a forecast for its development in the
medium and long term. It provides a comprehensive overview of the
market value, dynamics, segmentation, main players, growth and
demand drivers, challenges & future outlook, etc. This is one of the
most comprehensive reports about the India Patient Support
Programs (PSP) Market, and offers unmatched value, accuracy, and
expert insights.
3 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
Report Scope
4 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
CONTENT PG. NO.
1. India Patient Support Programs (PSP) Market Overview 07-17
1.1. Patient Support Programs (PSP) Overview
1.2. Patient Support Programs (PSP) Scenario in the World
1.3. India Overview
1.4. Economic Overview: India
1.5. Statistics at a Glance
1.6. Healthcare Scenario in India
1.7. Budget of Indian Government for Public Insurance
1.8. Top Developments in India
2. Patient Support Programs (PSP) Overview 18-21
2.1. Categories of Patient Support Programs
2.2. PSP Landscape in India
2.3. PSP Model in India
Table of Content
CONTENT PG. NO.
1. India Patient Support Programs (PSP) Market Overview 07-17
1.1. Patient Support Programs (PSP) Overview
1.2. Patient Support Programs (PSP) Scenario in the World
1.3. India Overview
1.4. Economic Overview: India
1.5. Statistics at a Glance
1.6. Healthcare Scenario in India
1.7. Budget of Indian Government for Public Insurance
1.8. Top Developments in India
2. Patient Support Programs (PSP) Overview 18-21
2.1. Categories of Patient Support Programs
2.2. PSP Landscape in India
2.3. PSP Model in India
Table of Content
5 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
CONTENT PG. NO.
3. Market Size and Forecasting 22-27
3.1. Market Size and Forecasts (Excel and Methodology)
3.2. Market Segmentation
3.2.1. Therapeutic Area
3.2.2. Type
4. Market Dynamics 28-33
4.1. Market Growth Drivers
4.2. Market Restraints
5. Competitive Landscape 34-43
5.1. Major Market Share
5.2. Key Players in India Patient Support Programs (PSP) Market
5.2.1. Janssen Pharmaceutical
5.2.2. Roche
Table of Content
CONTENT PG. NO.
3. Market Size and Forecasting 22-27
3.1. Market Size and Forecasts (Excel and Methodology)
3.2. Market Segmentation
3.2.1. Therapeutic Area
3.2.2. Type
4. Market Dynamics 28-33
4.1. Market Growth Drivers
4.2. Market Restraints
5. Competitive Landscape 34-43
5.1. Major Market Share
5.2. Key Players in India Patient Support Programs (PSP) Market
5.2.1. Janssen Pharmaceutical
5.2.2. Roche
Table of Content
6 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
CONTENT PG. NO.
5.2.3. Pfizer
5.2.4. Sanofi
5.2.5. Novartis
5.2.6. Takeda
5.2.7. Biocon Ltd
5.2.8. Dr. Reddy’s Laboratories
5.2.9. Cipla
5.2.10. Lupin
6. Regulatory Landscape 44-48
6.1. Regulations in India
6.2. Reimbursement Process
Table of Content
CONTENT PG. NO.
5.2.3. Pfizer
5.2.4. Sanofi
5.2.5. Novartis
5.2.6. Takeda
5.2.7. Biocon Ltd
5.2.8. Dr. Reddy’s Laboratories
5.2.9. Cipla
5.2.10. Lupin
6. Regulatory Landscape 44-48
6.1. Regulations in India
6.2. Reimbursement Process
Table of Content
India Patient Support Programs (PSP) Market Analysis
1. Market Overview
1. Market Overview
▪Patient Support Programs (PSPs) encompass initiatives led by pharmaceutical companies, aimed at
enhancing access, usage, and adherence to prescription drugs
▪Patient support programs assist patients in obtaining necessary medications and educate them on
proper usage, thereby increasing the likelihood of successful treatment
▪By providing crucial information upon initial prescription and offering continuous support throughout the
treatment process, PSPs aim to enhance healthcare for clients and ensure an improved overall
experience
Types of services provided by a PSPs:
PSPs can encompass a wide range of services, such as:
▪Temporary Supply Assistance: Offers a short-term supply of free product while awaiting coverage approval on
your plan
▪Financial Assistance: Assists with remaining costs after processing drug plan coverage
▪Nursing Services: Offers education, follow-up calls, or appointment coordination
▪Pharmacy Services: Coordinates drug shipment, dispensing, and delivery
▪Clinical Services: Provides drug administration (e.g., infusion or injection) and lab services if necessary
1.1 Patient Support Programs
enhancing access, usage, and adherence to prescription drugs
▪Patient support programs assist patients in obtaining necessary medications and educate them on
proper usage, thereby increasing the likelihood of successful treatment
▪By providing crucial information upon initial prescription and offering continuous support throughout the
treatment process, PSPs aim to enhance healthcare for clients and ensure an improved overall
experience
Types of services provided by a PSPs:
PSPs can encompass a wide range of services, such as:
▪Temporary Supply Assistance: Offers a short-term supply of free product while awaiting coverage approval on
your plan
▪Financial Assistance: Assists with remaining costs after processing drug plan coverage
▪Nursing Services: Offers education, follow-up calls, or appointment coordination
▪Pharmacy Services: Coordinates drug shipment, dispensing, and delivery
▪Clinical Services: Provides drug administration (e.g., infusion or injection) and lab services if necessary
1.1 Patient Support Programs
9 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
1.2 Patient Support Programs Scenario in the World
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1,589
Global Patient Support
Programs (PSPs) were
recorded as of April, 2020
57%
Consumers prioritize
ongoing support for
medication management
and dosage accuracy
$528 Bn
Is the annual cost
associated with morbidity
and mortality due to poor
medication adherence
71%
Of consumers consider it
very important for
pharmaceutical
companies to offer good
customer support
Illustrative
1.2 Patient Support Programs Scenario in the World
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1,589
Global Patient Support
Programs (PSPs) were
recorded as of April, 2020
57%
Consumers prioritize
ongoing support for
medication management
and dosage accuracy
$528 Bn
Is the annual cost
associated with morbidity
and mortality due to poor
medication adherence
71%
Of consumers consider it
very important for
pharmaceutical
companies to offer good
customer support
Illustrative
10 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
India Market
~$xx Bn Market
➢Africa: $_ _
➢APAC: $_ _
➢Europe: $_ _
➢LATAM: $_ _
➢Middle East: $_ _
➢North America: $_ _
Regional Analysis
Illustrative
1.2 Patient Support Programs Scenario in the World
India Market
~$xx Bn Market
➢Africa: $_ _
➢APAC: $_ _
➢Europe: $_ _
➢LATAM: $_ _
➢Middle East: $_ _
➢North America: $_ _
Regional Analysis
Illustrative
1.2 Patient Support Programs Scenario in the World
11 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Illustrative
1.3 India Overview
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1.42 Bn
Is the population of India in
2023
$3.92 Tn
Is the Gross Domestic
Product of India in 2023
28.2 years
Is the median age in India
in 2023
2.6%
Of India’s GDP is spent on
health in 2023
Illustrative
1.3 India Overview
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1.42 Bn
Is the population of India in
2023
$3.92 Tn
Is the Gross Domestic
Product of India in 2023
28.2 years
Is the median age in India
in 2023
2.6%
Of India’s GDP is spent on
health in 2023
12 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
1.33
1.35
1.36
1.38
1.39
1.41 1.41
1.42
2016 2017 2018 2019 2020 2021 2022 2023
Population of India, (In Bn)
$2.29
$2.65$2.70
$2.84
$2.67
$3.15
$3.42
$3.92
2016 2017 2018 2019 2020 2021 2022 2023
GDP of India, (in $Tn)
Population Split (2023)
Male
52%
Female
48%
By Age GroupBy Gender
▪In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
1.4 Economic Overview: India
25.3%
67.8%
25.3%
0-14 Yrs
15-64 Yrs
65+ Yrs
1.33
1.35
1.36
1.38
1.39
1.41 1.41
1.42
2016 2017 2018 2019 2020 2021 2022 2023
Population of India, (In Bn)
$2.29
$2.65$2.70
$2.84
$2.67
$3.15
$3.42
$3.92
2016 2017 2018 2019 2020 2021 2022 2023
GDP of India, (in $Tn)
Population Split (2023)
Male
52%
Female
48%
By Age GroupBy Gender
▪In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
1.4 Economic Overview: India
25.3%
67.8%
25.3%
0-14 Yrs
15-64 Yrs
65+ Yrs
13 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Illustrative
49%
Patient in India suffering
from non-communicable
diseases do not adhere to
their medications
96%
Doctors in India feel that
Patient Support Programs
can improve patient
outcomes
75%
Pharmaceuticals in India
have outsourced their
Patient Support Program
1759
Drugs are offered through
the government Patient
Assistance Program in
India
1.5 Statistics at a Glance: Patient Support Programs Market in India
▪In this section you will get an
understanding of the patient support
programs market, which includes important
statistics and other details related to the
topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Illustrative
49%
Patient in India suffering
from non-communicable
diseases do not adhere to
their medications
96%
Doctors in India feel that
Patient Support Programs
can improve patient
outcomes
75%
Pharmaceuticals in India
have outsourced their
Patient Support Program
1759
Drugs are offered through
the government Patient
Assistance Program in
India
1.5 Statistics at a Glance: Patient Support Programs Market in India
▪In this section you will get an
understanding of the patient support
programs market, which includes important
statistics and other details related to the
topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
14 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Public Healthcare
▪Public sector includes government-funded healthcare facilities
such as primary health centers, district hospitals, and tertiary care
hospitals
▪Urban areas generally have better healthcare facilities, including
multi-specialty hospitals and advanced medical technology
Private Healthcare
▪Private sector consists of private hospitals, clinics, and diagnostic
centers, which cater to a significant portion of the population
▪These offer a wider range of services that are of higher quality
with short wait times but come at a greater cost
Insurance
▪Public: Government has implemented schemes like Ayushman
Bharat, which aims to provide health insurance coverage to
economically vulnerable sections of the population
▪Private: Private insurance companies offer health insurance
policies that cover medical expenses
Government Programs
▪Government has launched various initiatives to improve
healthcare in India
▪These include the National Health Mission, which aims to provide
accessible, affordable, and quality healthcare to all citizens
▪Additionally, there is an ongoing focus on digital health initiatives
and telemedicine services to enhance healthcare accessibility
1.6 Healthcare Scenario in India
Illustrative
Public Healthcare
▪Public sector includes government-funded healthcare facilities
such as primary health centers, district hospitals, and tertiary care
hospitals
▪Urban areas generally have better healthcare facilities, including
multi-specialty hospitals and advanced medical technology
Private Healthcare
▪Private sector consists of private hospitals, clinics, and diagnostic
centers, which cater to a significant portion of the population
▪These offer a wider range of services that are of higher quality
with short wait times but come at a greater cost
Insurance
▪Public: Government has implemented schemes like Ayushman
Bharat, which aims to provide health insurance coverage to
economically vulnerable sections of the population
▪Private: Private insurance companies offer health insurance
policies that cover medical expenses
Government Programs
▪Government has launched various initiatives to improve
healthcare in India
▪These include the National Health Mission, which aims to provide
accessible, affordable, and quality healthcare to all citizens
▪Additionally, there is an ongoing focus on digital health initiatives
and telemedicine services to enhance healthcare accessibility
1.6 Healthcare Scenario in India
Illustrative
15 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
1.7 Budget of Indian Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20312022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
1.7 Budget of Indian Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20312022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
16 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
1.8 Top Developments in India
Company Name Type
Amount /
Duration
Year Key Pointers
New Launch - 2023
▪Lupin Limited has introduced Humrahi, a patient support program
that marks the beginning of a new era in diabetes management
by focusing on adherence, behavior, and transformation
▪It provides extensive support by focusing on essential aspects of
therapy adherence, including personalized diet counseling,
medication assistance, and customized lifestyle modifications, all
overseen by healthcare professionals
New Launch - 2023
▪Takeda has introduced the Sunrise Patient Services Program for
Hereditary Angioedema (HAE) in India
▪This patient support program focuses on four key elements:
Awareness, Screening & Diagnosis, Treatment, and Maintenance
Support
▪Implemented by an independent patient services agency funded
by Takeda, the program offers field counseling and tele-support
services, free HAE testing at quality diagnostic labs, and
assistance with treatment reimbursement, among other services
Latest Deals in India
Illustrative
1.8 Top Developments in India
Company Name Type
Amount /
Duration
Year Key Pointers
New Launch - 2023
▪Lupin Limited has introduced Humrahi, a patient support program
that marks the beginning of a new era in diabetes management
by focusing on adherence, behavior, and transformation
▪It provides extensive support by focusing on essential aspects of
therapy adherence, including personalized diet counseling,
medication assistance, and customized lifestyle modifications, all
overseen by healthcare professionals
New Launch - 2023
▪Takeda has introduced the Sunrise Patient Services Program for
Hereditary Angioedema (HAE) in India
▪This patient support program focuses on four key elements:
Awareness, Screening & Diagnosis, Treatment, and Maintenance
Support
▪Implemented by an independent patient services agency funded
by Takeda, the program offers field counseling and tele-support
services, free HAE testing at quality diagnostic labs, and
assistance with treatment reimbursement, among other services
Latest Deals in India
Illustrative
17 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
1.8 Top Developments in India (Continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals in India
Illustrative
1.8 Top Developments in India (Continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals in India
Illustrative
India Patient Support Programs (PSP) Market Analysis
2. Patient Support Programs Overview
2. Patient Support Programs Overview
19 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
2.1 Categories of Patient Support Programs
▪Target patients' medication
persistence, particularly in cases
involving complex regimens,
side effects, and conditions
where treatment effects may not
be immediately evident
▪Offer comprehensive support
including education on
adherence, counseling,
assistance with adverse event
reporting, and resources to help
healthcare professionals
effectively manage patient
adherence
▪Focus on alleviating financial
and affordability concerns for
patients, whether at the onset
or continuation of treatment
▪Provide guidance and
assistance in navigating
regulatory changes,
establishing funding avenues,
and managing financial aid for
eligible patients, all while
ensuring adherence to
regulatory requirements
▪Provide aid to patients who
face barriers in traveling for
treatment administration or
accessing hospitals for clinical
needs
▪Address a range of challenges
including drug accessibility,
management of clinical
workload, and overcoming
transportation limitations for
patients, ensuring
comprehensive support for the
successful delivery of treatment
Adherence Support Financial Assistance Clinical Support
2.1 Categories of Patient Support Programs
▪Target patients' medication
persistence, particularly in cases
involving complex regimens,
side effects, and conditions
where treatment effects may not
be immediately evident
▪Offer comprehensive support
including education on
adherence, counseling,
assistance with adverse event
reporting, and resources to help
healthcare professionals
effectively manage patient
adherence
▪Focus on alleviating financial
and affordability concerns for
patients, whether at the onset
or continuation of treatment
▪Provide guidance and
assistance in navigating
regulatory changes,
establishing funding avenues,
and managing financial aid for
eligible patients, all while
ensuring adherence to
regulatory requirements
▪Provide aid to patients who
face barriers in traveling for
treatment administration or
accessing hospitals for clinical
needs
▪Address a range of challenges
including drug accessibility,
management of clinical
workload, and overcoming
transportation limitations for
patients, ensuring
comprehensive support for the
successful delivery of treatment
Adherence Support Financial Assistance Clinical Support
20 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
2.2 PSP Landscape in India
75%
25%
Outsourced Not outsourced
Mode of Pharmaceutical PSPs in India, (in %), 2023 Therapeutic Areas Addressed by PSPs in India, (in %), 2023
Anemia
IBD
Hairfall
Cancer
Respiratory
Hep B
Diabetes
TB
▪PSPs in India are provided by top global and local companies and the most common mode is by outsourcing it to third-party providers
▪Engagement types commonly used by these PSPs include Telephonic services, in-person consultations and mixed approach
2.2 PSP Landscape in India
75%
25%
Outsourced Not outsourced
Mode of Pharmaceutical PSPs in India, (in %), 2023 Therapeutic Areas Addressed by PSPs in India, (in %), 2023
Anemia
IBD
Hairfall
Cancer
Respiratory
Hep B
Diabetes
TB
▪PSPs in India are provided by top global and local companies and the most common mode is by outsourcing it to third-party providers
▪Engagement types commonly used by these PSPs include Telephonic services, in-person consultations and mixed approach
21 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
2.3 PSP Model in India
For Pharmaceuticals
Profile Patient Outsource Evaluate
Outsourcing to
third-party
agencies
Audit the
provision of
services
Studying
patient journey
Profiling
eligible
patients
For Patients
Financial Assistance Round the Clock Support Home Delivery Services Caregiver Education
2.3 PSP Model in India
For Pharmaceuticals
Profile Patient Outsource Evaluate
Outsourcing to
third-party
agencies
Audit the
provision of
services
Studying
patient journey
Profiling
eligible
patients
For Patients
Financial Assistance Round the Clock Support Home Delivery Services Caregiver Education
India Patient Support Programs (PSP) Market Analysis
3. Market Size and Forecasting
3. Market Size and Forecasting
23 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
XX
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
India Patient Support Programs (PSP) Market Forecast, 2023-2030
Click on the icon to know the calculations and assumption
20232024202520262027202820292030
Major Markets Patient
($Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
India Patient Size ($Bn)0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75%21.70%23.56%23.45%23.42%23.39%23.34%23.45%
Global Market Size ($Bn)3,6203,7803,9504,1284,3144,5084,7114,937
India Market Size ($Bn)61 74 84 87 91 95 99 106
Illustrative
3.1 Market Size and Forecasts (Excel and Methodology)
▪In this section you will get an
understanding of the topic, which includes
the number of patient support programs,
therapeutic areas, and other details related
to the topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
XX
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
India Patient Support Programs (PSP) Market Forecast, 2023-2030
Click on the icon to know the calculations and assumption
20232024202520262027202820292030
Major Markets Patient
($Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
India Patient Size ($Bn)0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75%21.70%23.56%23.45%23.42%23.39%23.34%23.45%
Global Market Size ($Bn)3,6203,7803,9504,1284,3144,5084,7114,937
India Market Size ($Bn)61 74 84 87 91 95 99 106
Illustrative
3.1 Market Size and Forecasts (Excel and Methodology)
▪In this section you will get an
understanding of the topic, which includes
the number of patient support programs,
therapeutic areas, and other details related
to the topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
24 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
▪In this section you will get an understanding of the segmentations which will cover the India Patient Support Programs (PSP) Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Therapeutic Area
Oncology
Neurology
Diabetes
Rare Diseases
Others
Type
Financial Assistance
Medication Adherence
Support Services
Others
Illustrative
3.2 Snapshot of Patient Support Programs Market Segmentation
▪In this section you will get an understanding of the segmentations which will cover the India Patient Support Programs (PSP) Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Therapeutic Area
Oncology
Neurology
Diabetes
Rare Diseases
Others
Type
Financial Assistance
Medication Adherence
Support Services
Others
Illustrative
3.2 Snapshot of Patient Support Programs Market Segmentation
25 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
India Patient Support Programs (PSP) Market Share, By
Therapeutic Area (2023)
Oncology
Neurology
Diabetes
Rare Diseases
Others
Illustrative
3.2.1 Market Segmentation: By Therapeutic Area
▪In this section you will get an
understanding of the topic, which includes
the segmentation of the Indian Patient
Support Program Market based on
Therapeutic Area
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
India Patient Support Programs (PSP) Market Share, By
Therapeutic Area (2023)
Oncology
Neurology
Diabetes
Rare Diseases
Others
Illustrative
3.2.1 Market Segmentation: By Therapeutic Area
▪In this section you will get an
understanding of the topic, which includes
the segmentation of the Indian Patient
Support Program Market based on
Therapeutic Area
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
26 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
India Patient Support Programs (PSP) Market Share, By Type
(2023)
Financial
Assistance
Medication
Adherence
Support Services
Others
Illustrative
3.2.2 Market Segmentation: By Type
▪In this section you will get an
understanding of the topic, which includes
the segmentation of the Indian Patient
Support Program Market based on Type
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
India Patient Support Programs (PSP) Market Share, By Type
(2023)
Financial
Assistance
Medication
Adherence
Support Services
Others
Illustrative
3.2.2 Market Segmentation: By Type
▪In this section you will get an
understanding of the topic, which includes
the segmentation of the Indian Patient
Support Program Market based on Type
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
India Patient Support Programs (PSP) Market Analysis
4. Market Dynamics
4. Market Dynamics
28 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
4. Snapshot Of Market Growth Drivers And Restraints
Illustrative
4.1.1
Growing need to
manage chronic
diseases with highest
mortality rate of ~70%
in India
4.1.2
Rising focus of
patients on
personalized and
patient-centric care
4.1.3
Rapidly aging
population of 153
Mn creating
demand for PSPs
4.2.1
Increasing use of
digital tools in PSPs
raises concerns about
data privacy and
security
4.2.2
Limited awareness
and lack of
integration
4. Snapshot Of Market Growth Drivers And Restraints
Illustrative
4.1.1
Growing need to
manage chronic
diseases with highest
mortality rate of ~70%
in India
4.1.2
Rising focus of
patients on
personalized and
patient-centric care
4.1.3
Rapidly aging
population of 153
Mn creating
demand for PSPs
4.2.1
Increasing use of
digital tools in PSPs
raises concerns about
data privacy and
security
4.2.2
Limited awareness
and lack of
integration
29 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
4.1.1 Growing need to manage chronic diseases with highest mortality rate of
~70% in India
Illustrative
Cancer
Diabetes
Obesity
Hypertension
Others
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Burden of Chronic Diseases in India, (%)
4.1.1 Growing need to manage chronic diseases with highest mortality rate of
~70% in India
Illustrative
Cancer
Diabetes
Obesity
Hypertension
Others
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Burden of Chronic Diseases in India, (%)
30 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2022 2030
Illustrative
4.1.2 Rising focus of patients on personalized and patient-centric care
Population Adopting Personalized Care in India, (%)
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2022 2030
Illustrative
4.1.2 Rising focus of patients on personalized and patient-centric care
Population Adopting Personalized Care in India, (%)
31 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
4.1.3 Rapidly aging population of 153 Mn creating demand for PSPs
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
2022 2024 2026 2028 2030
Aging Demographic of India, (Mn)
4.1.3 Rapidly aging population of 153 Mn creating demand for PSPs
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
2022 2024 2026 2028 2030
Aging Demographic of India, (Mn)
32 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
4.2.1 Increasing use of digital tools in PSPs
raises concerns about data privacy and security
▪Please be aware that this sample report is intended to
provide you with a brief overview of the kind of
information and analysis that will be presented in the final
report
▪In order to obtain access to all of the information that you
are seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it
will include data, analysis, trends, and other relevant
information related to the topic or subject matter of
interest
4.2.2 Limited awareness among patients and lack
of integration restrict the growth of PSPs
▪Please be aware that this sample report is intended to
provide you with a brief overview of the kind of
information and analysis that will be presented in the final
report
▪In order to obtain access to all of the information that you
are seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it
will include data, analysis, trends, and other relevant
information related to the topic or subject matter of
interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Restraints
4.2.1 Increasing use of digital tools in PSPs
raises concerns about data privacy and security
▪Please be aware that this sample report is intended to
provide you with a brief overview of the kind of
information and analysis that will be presented in the final
report
▪In order to obtain access to all of the information that you
are seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it
will include data, analysis, trends, and other relevant
information related to the topic or subject matter of
interest
4.2.2 Limited awareness among patients and lack
of integration restrict the growth of PSPs
▪Please be aware that this sample report is intended to
provide you with a brief overview of the kind of
information and analysis that will be presented in the final
report
▪In order to obtain access to all of the information that you
are seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it
will include data, analysis, trends, and other relevant
information related to the topic or subject matter of
interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Restraints
India Patient Support Programs (PSP) Market Analysis
5. Competitive Landscape
5. Competitive Landscape
34 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
Revenue of Major players in the India Patient Support
Programs (PSP) Market ($ Mn)
Illustrative
5.1 Major Market Share
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
Revenue of Major players in the India Patient Support
Programs (PSP) Market ($ Mn)
Illustrative
5.1 Major Market Share
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
35 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Janssen
Pharmaceutical
1 Takeda6
Roche2 Biocon Ltd7
Pfizer3
Dr. Reddy’s
Laboratories
8
Sanofi4 Cipla9
Novartis5 Lupin10
5.2 Key Players in India Patient Support Programs (PSP) Market
Illustrative
▪Here is the list of top 10 companies which
will cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Janssen
Pharmaceutical
1 Takeda6
Roche2 Biocon Ltd7
Pfizer3
Dr. Reddy’s
Laboratories
8
Sanofi4 Cipla9
Novartis5 Lupin10
5.2 Key Players in India Patient Support Programs (PSP) Market
Illustrative
▪Here is the list of top 10 companies which
will cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
36 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
5.2.1 Janssen – Johnson & Johnson
Founded in: 1953
HQ: Beerse, Belgium
Type: Private
Revenue: $85.19 Bn (Global)
Website: Janssen
▪Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is
a pharmaceutical company at the forefront of medical research
and development, focusing on various therapeutic areas
▪With over 45,000 employees worldwide, Janssen is committed to
reinventing healthcare and tackling society's most pressing
health challenges
▪It has been instrumental in developing a wide range of drugs for
human medical disorders, including mental illness and cancer
Therapeutic Areas
➢Oncology
➢Infectious Diseases
➢Cardiology
➢Immunology
Patient Support Program by Janssen
▪Icare4u is a patient support program by Janssen, the pharmaceutical division of Johnson & Johnson Private
Limited (J&J Pvt. Ltd)
▪In collaboration with healthcare professionals (HCPs) and wellness experts, the Icare4u website aims to
provide relevant information and support tools, to help patients and caregivers impacted by Chronic
Immunological Diseases to manage their mental and emotional well-being
▪It provides support for diseases such as Ulcerative Colitis, Rheumatoid Arthritis, among others
5.2.1 Janssen – Johnson & Johnson
Founded in: 1953
HQ: Beerse, Belgium
Type: Private
Revenue: $85.19 Bn (Global)
Website: Janssen
▪Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is
a pharmaceutical company at the forefront of medical research
and development, focusing on various therapeutic areas
▪With over 45,000 employees worldwide, Janssen is committed to
reinventing healthcare and tackling society's most pressing
health challenges
▪It has been instrumental in developing a wide range of drugs for
human medical disorders, including mental illness and cancer
Therapeutic Areas
➢Oncology
➢Infectious Diseases
➢Cardiology
➢Immunology
Patient Support Program by Janssen
▪Icare4u is a patient support program by Janssen, the pharmaceutical division of Johnson & Johnson Private
Limited (J&J Pvt. Ltd)
▪In collaboration with healthcare professionals (HCPs) and wellness experts, the Icare4u website aims to
provide relevant information and support tools, to help patients and caregivers impacted by Chronic
Immunological Diseases to manage their mental and emotional well-being
▪It provides support for diseases such as Ulcerative Colitis, Rheumatoid Arthritis, among others
37 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Company Name Type
Amount /
Duration
Year Key Pointers
Drug Acquisition$1.25 Bn May, 2024
▪Johnson & Johnson has reached an agreement to acquire the
rights to an experimental treatment for a skin disorder from the
privately held company Numab Therapeutics
▪This treatment, known as NM26, has recently completed early-
stage clinical trials. NM26 is part of a class of medications known
as bi-specific antibodies, which are engineered proteins capable
of targeting two distinct disease pathways simultaneously
Latest Deals - Mergers and Acquisitions
5.2.1 Janssen – Johnson & Johnson (Continued)
Illustrative
Company Name Type
Amount /
Duration
Year Key Pointers
Drug Acquisition$1.25 Bn May, 2024
▪Johnson & Johnson has reached an agreement to acquire the
rights to an experimental treatment for a skin disorder from the
privately held company Numab Therapeutics
▪This treatment, known as NM26, has recently completed early-
stage clinical trials. NM26 is part of a class of medications known
as bi-specific antibodies, which are engineered proteins capable
of targeting two distinct disease pathways simultaneously
Latest Deals - Mergers and Acquisitions
5.2.1 Janssen – Johnson & Johnson (Continued)
Illustrative
38 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
5.2.1 Janssen – Johnson & Johnson (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
5.2.1 Janssen – Johnson & Johnson (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
39 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
5.2.2 Roche
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Telemedicine Recent Activity / Press Coverage
5.2.2 Roche
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Telemedicine Recent Activity / Press Coverage
40 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
5.2.2 Roche (Continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
5.2.2 Roche (Continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
41 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
5.2.2 Roche (Continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
5.2.2 Roche (Continued)
42 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
xx
xx
xx
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
5.2.2 Roche (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
xx
xx
xx
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
5.2.2 Roche (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
India Patient Support Programs (PSP) Market Analysis
6. Regulatory Landscape
6. Regulatory Landscape
44 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
There is no single, comprehensive set of regulations governing patient support programs (PSPs) in India, however, there are indirect regulations
and guidelines that influence their operation. Some key regulations for PSPs in India are as below:
▪Drugs and Cosmetics Act & Rules (1940 & Rules): This act establishes the Drugs Controller General of India (DCGI) as the authority for
regulating drugs and medical devices. This act emphasizes ethical marketing practices and fair competition within the pharmaceutical
industry
▪Medical Council of India (MCI) Ethics Regulations (2009): These regulations, now under the purview of the National Medical Commission
(NMC), outline ethical considerations for interactions between doctors and pharmaceutical companies. This influences how pharmaceutical
companies design and implement patient support programs to avoid undue influence on prescribing practices
▪Department of Pharmaceuticals (DoP) Guidelines: The DoP occasionally issues guidelines related to interactions between
pharmaceutical companies and healthcare professionals. These guidelines might touch upon acceptable practices for patient support
programs
▪Information Technology Act, 2000: The Information Technology Act governs electronic records and digital transactions in India. Patient
support programs that involve the use of digital platforms or Patient Support Programs (PSP) must adhere to the data protection and privacy
requirements under this Act.
Illustrative
Regulations For Patient Support Programs
6.1 Regulations in India
There is no single, comprehensive set of regulations governing patient support programs (PSPs) in India, however, there are indirect regulations
and guidelines that influence their operation. Some key regulations for PSPs in India are as below:
▪Drugs and Cosmetics Act & Rules (1940 & Rules): This act establishes the Drugs Controller General of India (DCGI) as the authority for
regulating drugs and medical devices. This act emphasizes ethical marketing practices and fair competition within the pharmaceutical
industry
▪Medical Council of India (MCI) Ethics Regulations (2009): These regulations, now under the purview of the National Medical Commission
(NMC), outline ethical considerations for interactions between doctors and pharmaceutical companies. This influences how pharmaceutical
companies design and implement patient support programs to avoid undue influence on prescribing practices
▪Department of Pharmaceuticals (DoP) Guidelines: The DoP occasionally issues guidelines related to interactions between
pharmaceutical companies and healthcare professionals. These guidelines might touch upon acceptable practices for patient support
programs
▪Information Technology Act, 2000: The Information Technology Act governs electronic records and digital transactions in India. Patient
support programs that involve the use of digital platforms or Patient Support Programs (PSP) must adhere to the data protection and privacy
requirements under this Act.
Illustrative
Regulations For Patient Support Programs
6.1 Regulations in India
45 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
6.1 Regulations in India (Continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in India healthcare system, with payers and providers increasingly focused on improving patient outcomes
and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
6.1 Regulations in India (Continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in India healthcare system, with payers and providers increasingly focused on improving patient outcomes
and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
46 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
6.2 Reimbursement Process
The reimbursement process in India healthcare system can be complex and can vary depending on the type of healthcare service, the
healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
6.2 Reimbursement Process
The reimbursement process in India healthcare system can be complex and can vary depending on the type of healthcare service, the
healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
47 A Sample Report on India Patient Support Programs (PSP) Market Analysis I Confidential
6.2 Reimbursement Process (Continued)
The reimbursement process in India healthcare system can be complex and
can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
6.2 Reimbursement Process (Continued)
The reimbursement process in India healthcare system can be complex and
can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
A division of
Life-sciences Market Research
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
At Insights10, our extensive report
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)
Click on the country to see the reports
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• India
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• India
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
What do our reports cover?
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
01 0302 04 05
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Bottom Up Approach
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
2023
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
We have access to a multitude of highly
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
Reliable
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Yearly Access
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
@Our Team
@Work
Beyond Work
… and many more
Pi-SM
GmbH
Our Clients
Pi-SM
GmbH
Our Clients
I've had the pleasure of availing Insights10’s services several times, and I've always
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
Dear Insights10 Team, I wanted to thank you all for the great work you conducted
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
Michael Blumberg Youssef Mallat
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say
Thank You
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
Categories
BusinessDownload
Download Slideshow Get the original presentation fileQuick Actions
Statistics
- Views 160
- Slides 68
- Age 480 days
Related Slideshows
1
DTI BPI Pivot Small Business - BUSINESS START UP PLAN
MeljunCortes
28 views
1
CATHOLIC EDUCATIONAL Corporate Responsibilities
MeljunCortes
30 views
11
Karin Schaupp – Evocation; lançamento: 2000
alfeuRIO
28 views
10
Pillars of Biblical Oneness in the Book of Acts
JanParon
26 views
31
7-10. STP + Branding and Product & Services Strategies.pptx
itsyash298
27 views
44
Business Legislation PPT - UNIT 1 jimllpkggg
slogeshk98
29 views